Global Shuanghuanglian Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Shuanghuanglian Market Insights, Forecast to 2034
Shuanghuanglian in the name of Shuanghuanglian refers to Shuanghua (honeysuckle) and Coptis chinensis. Its main ingredients are Shuanghua, Coptis chinensis and Forsythia chinensis. The first character of these three Chinese medicine names is taken, so it is called Shuanghuanglian.
Global Shuanghuanglian market is expected to reach to US$ 175 million in 2024, with a positive growth of %, compared with US$ 170 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Shuanghuanglian industry is evaluated to reach US$ 210.2 million in 2029. The CAGR will be 3.1% during 2024 to 2029.
Shuanghuanglian is mainly sold and used in China and other areas where traditional Chinese medicine is popular. In recent years, TCM has gained recognition and acceptance not only in Asia, but also in other parts of the world. The global market for TCM products has been expanding, driven by factors such as growing interest in naturopathic and holistic therapies, growing awareness about the efficacy of TCM, and rising consumer demand for alternative and complementary medicines. Shuanghuanglian, a well-known traditional Chinese medicine preparation, can benefit from this market growth.
Report Covers
This report presents an overview of global Shuanghuanglian market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Shuanghuanglian market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Harbin Pharm
Zhenbaodao Group
Lin Bao Pharmaceutical
Nanyang Xinsheng
Asia Pharmaceutical
Tailong, Henan
Wandashan Pharmaceuticals
Dongsheng
.Fusen Pharma
CR Pharma
Furen
Hongtai
Beijing Yinjian Pharmaceutical
Most
Shandong Jixing Pharmaceutical
Segment by Type
Shuanghuanglian Granules
Shuanghuanglian Oral Liquid
Shuanghuanglian Injection
Online Sales
Offline Sales
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Shuanghuanglian plant distribution, commercial date of Shuanghuanglian, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Shuanghuanglian introduction, etc. Shuanghuanglian Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Shuanghuanglian
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Shuanghuanglian market is expected to reach to US$ 175 million in 2024, with a positive growth of %, compared with US$ 170 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Shuanghuanglian industry is evaluated to reach US$ 210.2 million in 2029. The CAGR will be 3.1% during 2024 to 2029.
Shuanghuanglian is mainly sold and used in China and other areas where traditional Chinese medicine is popular. In recent years, TCM has gained recognition and acceptance not only in Asia, but also in other parts of the world. The global market for TCM products has been expanding, driven by factors such as growing interest in naturopathic and holistic therapies, growing awareness about the efficacy of TCM, and rising consumer demand for alternative and complementary medicines. Shuanghuanglian, a well-known traditional Chinese medicine preparation, can benefit from this market growth.
Report Covers
This report presents an overview of global Shuanghuanglian market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Shuanghuanglian market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Harbin Pharm
Zhenbaodao Group
Lin Bao Pharmaceutical
Nanyang Xinsheng
Asia Pharmaceutical
Tailong, Henan
Wandashan Pharmaceuticals
Dongsheng
.Fusen Pharma
CR Pharma
Furen
Hongtai
Beijing Yinjian Pharmaceutical
Most
Shandong Jixing Pharmaceutical
Segment by Type
Shuanghuanglian Granules
Shuanghuanglian Oral Liquid
Shuanghuanglian Injection
Segment by Application
Online Sales
Offline Sales
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Shuanghuanglian plant distribution, commercial date of Shuanghuanglian, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Shuanghuanglian introduction, etc. Shuanghuanglian Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Shuanghuanglian
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports